李欣倫

助理教授, 放射線學科
主治醫師, 臺北醫學大學附設醫院

https://orcid.org/0000-0002-2905-7858

電子郵件132018@h.tmu.edu.tw

來源：Scopus
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。

每年研究成果

如果您對這些純文本內容做了任何改變，很快就會看到。

個人檔案

學歷

2014-2020 臺北醫學大學轉譯醫學博士學位學程博士
2000-2007 臺北醫學大學醫學系學士

經歷

臺北醫學大學附設醫院專任主治醫師
2021.01- 臺北醫學大學附設醫院放射腫瘤科主任
2020.11- 臺北醫學大學醫學系放射線學科助理教授
2019.08-2020.12 臺北醫學大學附設醫院放射腫瘤科代主任
2014.04-2015.06 臺北醫學大學附設醫院兼任主治醫師
2013.04-2014.09 壢新醫院兼任主治醫師
2012.11-2015.06 臺北市立萬芳醫院專任主治醫師

指紋

查看啟用 Hsin-Lun Lee 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。

12 類似的個人檔案

網路

國家層面的近期外部共同作業。通過按一下圓點深入探索詳細資料。

2 已完成

利用幹細胞及類器官技術剖析發炎性腸道疾病及消化道癌症的病理機轉並發展治療策略 (3/3)
Lee, H.
8/1/19 → 7/31/20
研究計畫: A - 政府部門 › b - 科技部
研究循環腫瘤細胞的基因型和表型在癌症病程中的動態變化及其臨床意義
Lee, H.
8/1/19 → 7/31/20
研究計畫: A - 政府部門 › b - 科技部

27 引文
3 h-指數
12 文章

Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts Survival and Liver Toxicity in Patients With Hepatocellular Carcinoma Treated With Stereotactic Ablative Radiation Therapy
Lo, C. H., Lee, H. L., Hsiang, C. W., Chiou, J. F., Lee, M. S., Chen, S. W., Shen, P. C., Lin, C. S., Chang, W. C., Yang, J. F., Dai, Y. H., Chen, C. Y., Chia-Hsien Cheng, J. & Huang, W. Y., 二月 1 2021, 於: International Journal of Radiation Oncology Biology Physics. 109, 2, p. 474-484 11 p.
研究成果: 雜誌貢獻 › 文章 › 同行評審
A combined systemic strategy for overcoming cisplatin resistance in head and neck cancer: From target identification to drug discovery
Chen, Y. J., You, G. R., Lai, M. Y., Lu, L. S., Chen, C. Y., Ting, L. L., Lee, H. L., Kanno, Y., Chiou, J. F. & Cheng, A. J., 十一月 2020, 於: Cancers. 12, 11, p. 1-20 20 p., 3482.
研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取
Ex vivo expansion and drug sensitivity profiling of circulating tumor cells from patients with small cell lung cancer
Lee, H. L., Chiou, J. F., Wang, P. Y., Lu, L. S., Shen, C. N., Hsu, H. L., Burnouf, T., Ting, L. L., Chou, P. C., Chung, C. L., Lee, K. L., Shiah, H. S., Liu, Y. L. & Chen, Y. J., 十一月 2020, 於: Cancers. 12, 11, p. 1-17 17 p., 3394.
研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取
Molecular-clinical correlation in pediatric medulloblastoma: A cohort series study of 52 cases in Taiwan
Wu, K. S., Ho, D. M. T., Jou, S. T., Yu, A. L., Tran, H. M., Liang, M. L., Chen, H. H., Lee, Y. Y., Chen, Y. W., Lin, S. C., Chang, F. C., Tsai, M. L., Liu, Y. L., Lee, H. L., Hsieh, K. L. C., Huang, W. C., Sung, S. Y., Chang, C. C., Changou, C. A., Liang, K. H. 及其他7, Hsieh, T. H., Liu, Y. R., Chao, M. E., Chen, W., Chu, S. S., Cho, E. C. & Wong, T. T., 三月 2020, 於: Cancers. 12, 3, 653.
研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取
1 引文斯高帕斯（Scopus）
Upregulation of protein synthesis and proteasome degradation confers sensitivity to proteasome inhibitor bortezomib in myc-atypical teratoid/rhabdoid tumors
Tran, H. M., Wu, K. S., Sung, S. Y., Changou, C. A., Hsieh, T. H., Liu, Y. R., Liu, Y. L., Tsai, M. L., Lee, H. L., Hsieh, K. L. C., Huang, W. C., Liang, M. L., Chen, H. H., Lee, Y. Y., Lin, S. C., Ho, D. M. T., Chang, F. C., Chao, M. E., Chen, W., Chu, S. S. 及其他4, Yu, A. L., Yen, Y., Chang, C. C. & Wong, T. T., 三月 22 2020, 於: Cancers. 12, 3, 752.
研究成果: 雜誌貢獻 › 文章 › 同行評審

開啟存取

MOESM3 of Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Lai, I. (Contributor), Lai, G. (Contributor), Chow, J. (Contributor), Lee, H. (Contributor), Yeh, C. (Contributor), Li, C. (Contributor), Yan, J. (Contributor), Chuang, S. (Contributor), Whang-Peng, J. (Contributor), Bai, K. (Contributor) & Yao, C. (Contributor), Unknown Publisher, 十一月 15 2017
DOI: 10.6084/m9.figshare.c.3931717_d3.v1, https://springernature.figshare.com/articles/journal_contribution/MOESM3_of_Active_fraction_HS7_from_Taiwanofungus_camphoratus_inhibits_AKT-mTOR_ERK_and_STAT3_pathways_and_induces_CDK_inhibitors_in_CL1-0_human_lung_cancer_cells/5606698/1
資料集: Dataset
Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Lai, I. (Contributor), Lai, G. (Contributor), Chow, J. (Contributor), Lee, H. (Contributor), Yeh, C. (Contributor), Li, C. (Contributor), Yan, J. (Contributor), Chuang, S. (Contributor), Whang-Peng, J. (Contributor), Bai, K. (Contributor) & Yao, C. (Contributor), Unknown Publisher, 十一月 15 2017
DOI: 10.6084/m9.figshare.c.3931717.v1, https://figshare.com/collections/Active_fraction_HS7_from_Taiwanofungus_camphoratus_inhibits_AKT-mTOR_ERK_and_STAT3_pathways_and_induces_CDK_inhibitors_in_CL1-0_human_lung_cancer_cells/3931717/1
資料集: Dataset
MOESM1 of Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Lai, I. (Contributor), Lai, G. (Contributor), Chow, J. (Contributor), Lee, H. (Contributor), Yeh, C. (Contributor), Li, C. (Contributor), Yan, J. (Contributor), Chuang, S. (Contributor), Whang-Peng, J. (Contributor), Bai, K. (Contributor) & Yao, C. (Contributor), Unknown Publisher, 十一月 15 2017
DOI: 10.6084/m9.figshare.c.3931717_d1.v1, https://springernature.figshare.com/articles/journal_contribution/MOESM1_of_Active_fraction_HS7_from_Taiwanofungus_camphoratus_inhibits_AKT-mTOR_ERK_and_STAT3_pathways_and_induces_CDK_inhibitors_in_CL1-0_human_lung_cancer_cells/5606626/1
資料集: Dataset
MOESM2 of Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Lai, I. (Contributor), Lai, G. (Contributor), Chow, J. (Contributor), Lee, H. (Contributor), Yeh, C. (Contributor), Li, C. (Contributor), Yan, J. (Contributor), Chuang, S. (Contributor), Whang-Peng, J. (Contributor), Bai, K. (Contributor) & Yao, C. (Contributor), Unknown Publisher, 十一月 15 2017
DOI: 10.6084/m9.figshare.c.3931717_d2.v1, https://springernature.figshare.com/articles/journal_contribution/MOESM2_of_Active_fraction_HS7_from_Taiwanofungus_camphoratus_inhibits_AKT-mTOR_ERK_and_STAT3_pathways_and_induces_CDK_inhibitors_in_CL1-0_human_lung_cancer_cells/5606662/1
資料集: Dataset